Lijun Chi
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study.
Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 01, 2026
SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease.
Journal: Molecular medicine reports
Published: October 30, 2025
Analyses of NOTCH3 variants in Chinese patients with clinically diagnosed Alzheimer's disease and frontotemporal dementia.
Journal: Alzheimer's research & therapy
Published: June 02, 2025
NTN-1 attenuates amyloid-β-mediated microglial neuroinflammation and memory impairment via the NF-κB pathway and NLRP3 inflammasome in a rat model of Alzheimer's disease.
Journal: Frontiers in aging neuroscience
Published: October 24, 2024
VISTA Alleviates Microglia-Mediated Neuroinflammation After Cerebral Ischemia-Reperfusion Injury via Regulating ACOD1/Itaconic Acid Metabolism.
Journal: Molecular neurobiology
Published: April 01, 2024
Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer's Disease Patients.
Journal: Frontiers in aging neuroscience
Published: August 22, 2021
Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1-42 Induced Alzheimer's Disease Model Rats.
Journal: Frontiers in aging neuroscience
Published: January 15, 2019
Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.
Journal: BMC neurology
Published: January 18, 2015
Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
Journal: Neurotoxicology
Published: April 10, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026